Antiarrhythmic actions of lidocaine.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004070:Digitalis / Q000037:antagonists & inhibitors; D004347:Drug Interactions; D004351:Drug Resistance; D006329:Heart Conduction System / Q000187:drug effects; D006352:Heart Ventricles; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D008102:Liver Circulation; D008862:Microsomes, Liver / Q000201:enzymology; D009203:Myocardial Infarction / Q000188:drug therapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D013610:Tachycardia / Q000188:drug therapy*; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D008012:Lidocaine